Adamas Pharmaceuticals, Inc.

Q1 2020 13F Holders

Symbol
ADMS
CUSIP
00548A106
Type
Equity
Class
COM
Num filings
75
Total reported value, excl. options
$44.8 M
Manager Report Date Value ($000) Shares Option Type